These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12003679)

  • 21. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
    Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
    J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
    Yui K; Ikemoto S; Ishiguro T; Goto K
    Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of NMDA receptors and the phencyclidine model of schizophrenia.
    Thornberg SA; Saklad SR
    Pharmacotherapy; 1996; 16(1):82-93. PubMed ID: 8700797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.
    Snyder SH
    Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia.
    Ito C
    Curr Pharm Des; 2002; 8(2):147-53. PubMed ID: 11812256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulant psychosis: systematic review.
    Curran C; Byrappa N; McBride A
    Br J Psychiatry; 2004 Sep; 185():196-204. PubMed ID: 15339823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
    Ago Y; Nakamura S; Arikawa S; Yata M; Matsuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):85-91. PubMed ID: 18516987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critique of the dopamine hypothesis of schizophrenia and psychosis.
    Moncrieff J
    Harv Rev Psychiatry; 2009; 17(3):214-25. PubMed ID: 19499420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.
    Grönig M; Atalla A; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):228-31. PubMed ID: 14673514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Angrist B; Duncan GE; Sheitman BB; Lieberman JA; Bracha SH; Ali SF
    Mol Psychiatry; 1999 Nov; 4(6):512-23. PubMed ID: 10578232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine regulates NR2B expression in Go2α knockout mice and thereby sustains behavioral sensitization.
    Brunk I; Sanchis-Segura C; Blex C; Perreau-Lenz S; Bilbao A; Spanagel R; Ahnert-Hilger G
    J Neurochem; 2010 Oct; 115(1):234-46. PubMed ID: 20649838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity.
    Pierce RC; Bari AA
    Rev Neurosci; 2001; 12(2):95-110. PubMed ID: 11392459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
    Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants].
    Ujike H
    Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):5-12. PubMed ID: 11233297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of gamma-aminobutyric acid (GABA)-benzodiazepine neurotransmission in an animal model of methamphetamine-induced psychosis.
    Ito K
    Hokkaido Igaku Zasshi; 1999 Mar; 74(2):135-44. PubMed ID: 10386162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the psychostimulant-sensitized animal model of schizophrenia.
    Shuto T; Nishi A
    CNS Neurosci Ther; 2011 Apr; 17(2):133-9. PubMed ID: 21159151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
    Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J
    Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
    Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
    J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
    Cauli O; Pinna A; Valentini V; Morelli M
    Neuropsychopharmacology; 2003 Oct; 28(10):1752-9. PubMed ID: 12865902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.